Published in Women's Health Weekly, December 13th, 2001
Their work was published in the November 2001 issue of Clinical Cancer Research, a scientific journal. Antisense therapy is a relatively new way of attacking cancer cells. The antisense approach involves a specific drug that inhibits the expression of a cancer-causing gene known as MDM2.
The MDM2 gene is overexpressed in several human cancers, including breast, lung and colon cancer. MDM2 wreaks its...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly